STERIS UK A.I CyberSecurity Scoring
25/03/2026
Access Monitoring Plan
Access Monitoring Plan
No incidents recorded for STERIS UK in 2026.
No incidents recorded for STERIS UK in 2026.
No incidents recorded for STERIS UK in 2026.
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. We partner with customers across the globe to help them solve their most complex challenges, architecting solutions that bring the power of science to life. Our global teams are pioneering what’s next across Life Sciences, Diagnostics, Biotechnology and beyond. For more information, visit www.danaher.com.
Olympus is passionate about creating customer-driven solutions for the medical industry. For more than 100 years, Olympus has focused on making people’s lives healthier, safer and more fulfilling by helping detect, prevent, and treat disease, furthering scientific research, and ensuring public safety. Olympus is headquartered in Tokyo, Japan, with more than 31,000 employees worldwide in nearly 40 countries and regions.
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is available at stryker.com and careers.stryker.com. Facts: ● 2024 Sales: $22.6 billion ● Industry: Medical Instruments & Supplies ● Employees: 53,000 worldwide ● 44+ Manufacturing and R&D Locations Worldwide ● $1.5 billion spent on research and development in 2024 ● ~14,200 patents owned globally in 2024 ● Products sold in ~75 countries ● Fortune 500 Company ● 9 consecutive years as one a World's Best Workplace Stryker’s social media community guidelines: https://www.stryker.com/content/m/legal/social-media-community-guidelines/en/index.html Notice Regarding Employee Conduct on Facebook/LinkedIn Meta/LinkedIn does not permit employers to verify or validate “employees” in the (META: “Works at” LinkedIn: “Experience”) section of users’ profiles. Please be aware that the views expressed by individuals on their personal accounts and do not necessarily represent the views of our company. If you encounter any issues with a person claiming to be our employee, we recommend using the “Report Profile” feature. If you’d like to report concerns to our Ethics Hotline, you may do so at: https://app.convercent.com/en-us/LandingPage/b6bb4e84-9fcb-ea11-a974-000d3ab9f296
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We advance our mission to alleviate pain and improve the quality of life for patients around the world with our innovative products and suite of integrated digital and robotic technologies leverage data, data analytics and artificial intelligence. Founded in 1927 and based in Warsaw, Zimmer Biomet has operations in more than 25 countries and sales in more than 100 countries. We maintain world-class scientific facilities and resources and collaborate with leading clinicians and researchers around the world. Awards and Recognitions • Forbes: America's Best Companies 2026 • Workhuman: Luminary Award 2025 & Innovator Award 2024 • TIME: America's Best Companies [Mid-Size] 2024 • Great Place to Work - Best Workplaces: Switzerland & Poland 2025 • Great Place to Work Certified 2025 - 2026: USA, Poland, India, Colombia, Ireland, Puerto Rico, Kingdom of Saudi Arabia, Switzerland • MedTech: Breakthrough Award Best New Technology Solution in Orthopedics 2025 • Top Employers Institute: China 2025 • VETS Indexes: 4 Star Employer 2025
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.com.
As a leading medical technology company, B. Braun protects and improves the health of people around the world. For more than 185 years, the family-owned company has been accelerating progress in health care with pioneering spirit and groundbreaking contributions. This innovative strength continues to be the foundation of B. Braun's success today—always with the goal of improving clinical outcomes, cost of care and patient benefits. More than 64,000 employees live Sharing Expertise worldwide, they make B. Braun a true partner that develops integrated solutions and sets new standards. By linking products, services and consulting, the company improves treatment processes and supports medical staff. In doing so, B. Braun always acts with future generations in mind, which is why responsibility for sustainable growth is embedded into all business processes. In 2024, the B. Braun Group generated sales of € 9.1 billion. Imprint: https://www.bbraun.com/en/imprint.html Privacy Policy: https://www.bbraun.com/en/privacy-policy.html
STERIS is a leading provider of infection prevention and other procedural products and services, focused primarily on healthcare, pharmaceutical and medical device Customers. MISSION WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe. VISION We strive to be a GREAT COMPANY. We provide world-class products and services for our Customers, safe and rewarding work for our people, and superior returns for our Shareholders. • $5 Billion in revenue in FY24 • More than 17,000 Associates worldwide • Over 4,000 Customer-facing professionals • Listed on the New York Stock Exchange under the symbol “STE” To learn more, visit www.steris.com. Want to join the team? View and apply for open roles at careers.steris.com.
A global leader in advanced diagnostics, Beckman Coulter has challenged convention to elevate the diagnostic laboratory’s role in improving patient health for more than 80 years. Our mission is to Relentlessly Reimagine Healthcare, One Diagnosis at a Time – and we do this by applying the power of science, technology and the passion and creativity of our teams. Our diagnostic solutions are used in complex clinical testing, and are found in hospitals, reference laboratories and physician office settings around the globe. We exist to deliver smarter, faster diagnostic solutions that move the needle forward from what’s now to what’s next. We do this by accelerating care with an extensive clinical menu, scalable lab automation technologies, insightful clinical informatics, and optimize lab performance services. Headquartered in Brea, Calif., Beckman Coulter Diagnostics has more than 11,000 global team members. Beckman Coulter is proud to be part of Danaher. Danaher is a global science and technology leader. Together we combine our capabilities to accelerate the real-life impact of tomorrow’s science and technology to improve human health.
Medline is the largest provider of medical-surgical products and supply chain solutions serving all points of care. Through its unique offering of world-class products, supply chain resilience and clinical practice expertise, Medline delivers improved clinical, financial and operational outcomes. Headquartered in Northfield, Illinois, the company employs 43,000 people worldwide and operates in over 100 countries and territories. To learn more about how Medline makes healthcare run better, visit www.medline.com.
Latest updates, reports, and threat intel affecting the global network.
Steris Corp., an infection control products and services company, plans to move its official headquarters from Ohio to the United Kingdom through a $1.9...
Steris offered to buy British sterilization services provider Synergy Health in a deal that would shift its domicile to the U.K. and cut its...
A flaw has been found in sigoden aichat up to 0.30.4. This affects an unknown function of the file src/serve.rs of the component API Endpoint. This manipulation causes uncontrolled memory allocation. The attack can be initiated remotely. The exploit has been published and may be used. The vendor was contacted early about this disclosure but did not respond in any way.
A vulnerability was detected in rowboatlabs rowboat up to 0.9.1. The impacted element is the function request.text/req.json of the file apps/rowboat/app/api/composio/webhook/route.ts of the component Composio Webhook Endpoint. The manipulation results in denial of service. It is possible to launch the attack remotely. The exploit is now public and may be used. Upgrading to version 0.9.2 is sufficient to resolve this issue. Upgrading the affected component is recommended. The legacy Next.js app was deleted at 0.9.2 rather than patched, leaving no security control behind.
A security vulnerability has been detected in Reader Tools PDF Reader App 98.8 on Android. The affected element is the function ActSplashNew.handleDeeplink of the component File Handler. The manipulation of the argument _display_name leads to path traversal. An attack has to be approached locally. The exploit has been disclosed publicly and may be used. The vendor was contacted early about this disclosure but did not respond in any way.
Windows ML CLI is a command line tool for building portable, performant, and high-quality AI models for Windows ML. Prior to 0.4.0, the src/winml/modelkit/serve/cli_api.py component exposes WinML CLI commands through a localhost HTTP API without authentication and configures the allow_origins setting as a wildcard in both src/winml/modelkit/serve/cli_api.py and src/winml/modelkit/serve/app.py. A malicious website loaded by a user can send cross-origin requests to /v1/cli/build or /v1/cli/config and set the trust_remote_code parameter to true, which is converted to the --trust-remote-code command-line flag without validation. This reaches AutoConfig.from_pretrained with trust_remote_code=True in src/winml/modelkit/loader/_autoconfig.py and imports Python code from an attacker-controlled model repository, resulting in arbitrary code execution as the server user. This issue is fixed in version 0.4.0.
fast-uri serializes the port component of a URI without validating it. When recomposing the authority, the userinfo and host components are escaped but the port is concatenated verbatim, so a port value that is not a sequence of digits can inject authority delimiters, demoting the intended host to userinfo and pointing the authority at an attacker-controlled host. Both fast-uri and Node's URL read the result back as the attacker's host with no error, so re-validating the built URI does not catch it. This affects applications that build URIs from parts and assign untrusted data to the port component through the serialize, normalize, or equal functions in their object forms. The issue affects fast-uri versions before 2.4.6, from 3.0.0 before 3.1.7, and from 4.0.0 before 4.1.4. It is fixed in 2.4.6, 3.1.7, and 4.1.4, where recomposeAuthority rejects any port that is not a digit sequence per RFC 3986.
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.